RT Journal Article
SR Electronic
T1 Theranostics in Perspective: White Paper
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP jnumed.125.269776
DO 10.2967/jnumed.125.269776
A1 Stokkel, Marcel P.M.
A1 Gotthardt, Martin
A1 Herrmann, Ken
A1 Gnanasegaran, Gopinath
YR 2025
UL http://jnm.snmjournals.org/content/early/2025/05/15/jnumed.125.269776.abstract
AB Nuclear medicine has evolved from a diagnostic-oriented speciality toward theranostics. Radionuclide therapy has become a booming business with newer radiopharmaceuticals and indications. Although the specialty of nuclear medicine seems scintillating, several challenges might limit sustained and long-term success. Some of the challenges and issues requiring clarification include radiopharmaceutical cost and supply, cost–benefit analysis, reimbursement, training, workforce, collaboration with the radiopharmaceutical industry, national and international nuclear medicine, and applied specialities. This review discusses these challenges and possible solutions to avoid speed breakers in theranostics.